Beyond PD-L1: Taking Away TIM3 and Tregs Stops Cancer Regrowth After Immunotherapy

CU Cancer Center study presented at AACR18 shows that TIM3 and/or increased regulatory T cells (Tregs) within a tumor may help cancers inactivate immune system killer T cells that would otherwise identify and attack the cancer.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News